+ All Categories
Home > Documents > MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director,...

MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director,...

Date post: 24-Dec-2015
Category:
Upload: francine-bethanie-wright
View: 215 times
Download: 0 times
Share this document with a friend
Popular Tags:
52
MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University
Transcript
Page 1: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

MOLES, MELANOMA and SKIN CANCER

Mary C. Martini, MD, FAADAssociate Professor Dermatology

Director, Melanoma and Pigmented Lesion ClinicNorthwestern University

Page 2: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

MOLES Everyone gets

moles They can get

bigger and darker due to sun burns and heavy sun exposure

Some families make “atypical” or irregular moles

Page 3: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

MOLES

Page 4: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

MOLES Benign or healthy

moles

Irregular moles-”dysplastic”

Melanoma

Page 5: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Dysplastic Nevus Multicolored Asymmetric

pigment deposition

Asymmetric contour-macular and papular

Indistinct margins

Page 6: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Atypical mole syndrome-(Dysplastic nevus

syndrome) >100 melanocytic

nevi 1 or more nevi

>8mm in diameter

1 or more dysplastic nevi on exam

Page 7: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Atypical Mole Syndrome has a 10 year risk of developing melanoma of 14%

Wang et al.JAAD 2005;50:15-20

Page 8: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Management of the Dysplastic Nevi Patient

Close monitoring- full body exams every 6 months

Dermoscopy of all atypical appearing nevi

Whole Body Photos Excision of any changing or

markedly atypical nevi

Page 9: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Body Mapping Studio

positioning stage indexed monostandbalanced cross-lighting

high resolution digital camera

body mapping software

Page 10: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

The Body Map

Page 11: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

At Home Exam

Page 12: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Dermoscopy The magnified visualization of pigmented skin

lesions beyond what would be visible by the physician

Increases diagnostic accuracy by 10-20%

Dermlite.com

Page 13: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Benign Nevireticulated pattern

Page 14: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Dysplastic Nevi

Page 15: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Asymmetric pigment pattern

Irregular depigmentation

Irregular edge

Dysplastic Nevi

Page 16: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Melanoma

Page 17: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
Page 18: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Melanoma

Page 19: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Changes in Overall Cancer Mortality (1975-2000)

Prostrate -5% Breast -15% Colorectal -25% MELANOMA +28%

Page 20: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Melanoma

Page 21: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Melanoma

Page 22: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Tumor Thickness- Breslow level

Level 5yr survival

<0.75mm 97.9%

0.76-1.49mm 91.7%

1.5-3.99mm 72.8% >4mm 57.5% Barnhill et al,Cancer 1996

Page 23: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Incidence of melanoma 1900 - 1 in 2000 2004 - 1 in 70 Major cause is ultraviolet exposure

Page 24: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
Page 25: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Tanning bed use before the age of 35 increases the risk

of skin cancer by 75%

Page 26: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

SUN DAMAGE

Page 27: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

PHOTOAGING Sun damage

Pollution

Heredity

Page 28: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

LENTIGOS “Sunspots or big

freckles” Increase in size

and color with more sun exposure

Areas with these growths may be areas that develop skin cancer years later

Page 29: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Lentigo

Page 30: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Lentigo

Page 31: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Photodamage

Page 32: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Actinic Keratosis

Page 33: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

SKIN CANCER Basal cell

carcinoma

Squamous cell skin cancer

Melanoma

Page 34: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Basal Cell Carcinoma Most common skin cancer Never metastasizes Sun damage is the major cause

Page 35: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Basal Cell Carcinoma

Page 36: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Basal Cell Carcinoma

Page 37: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Squamous Cell Carcinoma Second most common form of skin

cancer Can metastasize if neglected and

continues to grow Sun damage plays a major role

Page 38: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Squamous Cell Carcinoma Can occur in preexisting burn and

traumatic scars Can occur on lower lip due to

smoking or chewing tobacco in addition to actinic damage

Page 39: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Squamous Cell Carcinoma

Page 40: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Benign Lesions

Page 41: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Warts Caused by a virus Spread by shedding

skin Treated by “cryo”, 5FU or salicylic acid

plaster-oral/genital warts

linked to cervical and oral/throat cancer

Page 42: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

WARTS

Page 43: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Angiomas

Page 44: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Seborrheic Keratosis

Page 45: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
Page 46: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
Page 47: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Dermatofibromas

Page 48: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.
Page 49: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Sebaceous Hyperplasia

Page 50: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

SUNSCREENS Facial everyday sunscreens SPF 15-25: Eucerin

facial, Oil of Olay facial, Purpose

Chemical free- titanium dioxide and zinc oxide- Blue Lizard and Neutragena

Waterproof sunscreens SPF 35-70: Coppertone sport, Neutragena with helioplex, Blue lizard, in Canada or Europe sunscreens with Mexoryl

Reapply every 2 hours if swimming or sweating

Page 51: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Skin Cancer Prevention Skin protection involves use of

sunscreens including reapplication Wear sun screen containing

clothing and hats Avoid prolonged sun exposure

from 11 am to 3 pm

Page 52: MOLES, MELANOMA and SKIN CANCER Mary C. Martini, MD, FAAD Associate Professor Dermatology Director, Melanoma and Pigmented Lesion Clinic Northwestern University.

Recommended